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INTRODUCTION  
The yellow oleander (Thevetia peruviana) is an evergreen shrub or a small tree in 
the dogbane family Apocyananceae family that is  widely distributed to a broad area 
from Morocco and Portugal eastward through the Mediterranean region and southern 
Asia  to  southern  parts  of  China.  Their  beautiful  yellow flowers  and prolific  growth 
makes them popular shrubs for landscaping. 
     Oleander  is  one  of  the  most  poisonous  plants  and  contains  numerous  toxic 
compounds. All parts of the plant contain cardiac glycosides. The major toxic effects are 
similar  to  that  of  digoxin  overdose.  The  pathophysiology  includes  direct  glycoside 
inhibition of sodium-potassium pump of the heart and increased vagotonia. Symptoms 
include vomiting, diarrhea, dizziness, bradycardia, sinus and AV nodal block and other 
cardiac dysrhythmias2,3 Fatal,  DC shock resistant  ventricular  fibrillation or  refractory 
cardiogenic shock may occur in severely poisoned patients4.
Accidental ingestion occurs in children due to beautiful yellow flowers and the 
conspicuous  green  fruit5.  Accidental  poisonings  have  been  reported  form across  the 
world,  for  example  the  solomon Islands,  Brazil  and  Australia.  However,  intentional 
poisoning in these regions is very uncommon6. But the use of seeds / fruits of yellow 
oleander as a method of suicide is common only in Srilanka and South India. Since 1980 
there has been a sudden increase in the number of cases of suicidal yellow oleander 
poisoning in  Srilanka with thousands of  cases occurring each year now with a case 
fatality rate of at least 10%4. 
                     Though the poisoning is a common method of suicide in South India there  
has been no published reports regarding this poisoning from south India. Data regarding 
incidence  and  case  fatality  rate  of  this  poisoning  in  south  Inidan  population  is  not 
available.  The only Indian study involving large number of  patients  is  from Eastern 
India. (300 cases, Bose TK et al, 1999)7. Hyperkalemia which has been noted in about 
30% of  the  cases  of  yellow oleander  poisoning  in  a  Srilankan  study  has  not  been 
described in Indian studies involving 300 patients and 32 patients respectively  7,8. The 
risk  factors  for  cardiotoxicity  and  outcome  have  also  not  been  studied  in  detail  in 
previous studies. Moreover further studies are required to support the use multiple doses 
of activated charcoal and antidigoxin Fab fragments in yellow oleander poisoning.There 
has been only one clinical trial each to support their use in yellow oleander poisoning 
9,10.
                           So this study was undertaken to find out the incidence of yellow 
oleander poisoning among admissions in general  medicine wards of  our hospital,  to 
study the socio-clinical aspects, to find out correlation between clinical and biochemical 
parameters  with  electrocardiographic  changes  and  to  assess  possible  risk  factors  for 
cardiotoxicity and outcome and to compare the results with previous published reports. 
                                  AIMS AND OBJECTIVES
1. To find out the incidence of yellow oleander poisoning.
2. To analyse the clinico-social aspects.
3. To correlate clinical and biochemical data with electrocardiographic changes.
4. To identify the possible risk factors for cardio toxicity and outcome.
                        
                        
                         
                                       REVIEW OF LITERATURE
Yellow Oleander (Thevetia peruviana), - Plant description and distribution. 
It is a small ornamental tree belonging to family Apocynaceae which grows to 
about 10 to 15 feet high. The leaves are in pairs or whorls of three, thick and leathery, 
dark green, narrow lanceolate, 5-21 cm long and 1-3.5 cm broad, and with an entire 
margin. Flowers are bright yellow and funnel shaped with 5 petals spirally twisted. The 
flowers grow in clusters at the end of each branch; bright yellow, 2.5-5 cm diameter, 
with a deeply 5-lobed corolla with a fringe round the central corolla tube, which are 
often, but not always, sweetly scented. The fruits are somewhat globular, slightly fleshy 
and have a diameter of 4 to 5cm. The fruits which are green in colour, become black on 
ripening. Each fruit contains a single nut; light brown in colour and triangular in shape 
with two cells, each enclosing a pale yellow seed5.
           These plants are widely distributed throughout the tropical to the    sub temperate 
zones of  the world,  typically  occurs around dry stream beds.  Their  beautiful  yellow 
flowers and prolific growth makes them popular shrubs for landscaping. These plants 
also may be found growing wild1. It is often planted in numbers as a hedge11.
                        Yellow oleander tree (Thevetia peruviana)
                                      Yellow oleander flower
Historical and Medicolegal aspects 
     Many myths are associated with this plant. In the West Indies, the nut is carried in the 
pocket in the belief that it will ward off hemorrhoids. In East Africa, it is put in the hand 
of an infant at birth as a good luck token. In Africa, the seed kernels are occasionally 
chewed to cause purging. In the Philippines, half of one leaf in given as emetic and 
purgative. The sap and bark have been utilized in small amounts to treat malarial fever 
as well as to induce vomiting and purging. The sap also has been applied to sores and 
ulcers, also to tooth cavities and decayed teeth to relieve toothache11.
            The toxicity of the plant has been generally known since the sixteenth century. 
It's Sanskrit  name "Ashwamarak" is translated as horse killer11.  Accidental poisoning 
occurs  in  children  as  they  may  play  with  and  taste  the  bright  yellow  flowers  and 
conspicuous green fruit. The seeds are used for suicide attempts particularly by young 
people especially  in  northern parts  of  Srilanka and South India.  Other  medico legal 
aspects include use of roots and seeds with water or oil for procuring criminal abortion 
and seeds for poisoning cattle5. Yellow oleander glycosides proved effective in patients 
with heart failure and atrial fibrillation in studies carried out in 1930s, however digoxin 
has been preferred because of less frequent gastrointestinal side effects12.
Epidemiology of yellow oleander poisoning 
Ingestion  of  oleander  seeds  or  leaves  is  a  cause  of  accidental  poisoning 
worldwide, particularly among children  6,13.  Cases have been reported from places as 
diverse as Hawaii, the Solomon Islands, Southern Africa, Australia, Europe, the Far East 
and the United States14,15.  However the use of seeds /  fruits of yellow oleander as a 
method of suicide is common only in Srilanka and South India. This method of suicide 
is  common  among  adolescents  and  young  adults   with  a  female  preponderance  4,7. 
Currently, thousands of cases of yellow oleander poisoning occur in Srilanka every year 
with a case fatality rate of at least 10%4. The exact incidence of the disease in Indian 
population is not known. Bose TK et al (1999) noted a case fatality rate of 4.6% among 
300 cases in Eastern India7.
Poisonous parts
Generally, pulp of the seed is crushed into a paste for this purpose. All parts of the 
plant are poisonous especially the seeds / kernels of fruit16.
Poisonous agents 
       In  the  decreasing  order  of  potency  the  following  cardiac  glycosides  - 
Peruvoside,  Ruvoside,  Thevetin  A ,  Nerifolin,  Gerebrin  and  Thevetin  B17 are  the 
poisonous agents found in this plant.
Pathophysiology of toxicity 
The  poisonous  agents  found  in  yellow oleander  plant  are  cardiac  glycosides. 
These bind to a site on the cell membrane, producing reversible inhibition of sodium 
(Na+)  -  potassium  (K+)  -  adenosine  triphosphatase  (ATPase)  pump,  which  causes 
increased intracellular sodium concentrations and decreased intracellular potassium. In 
myocytes, elevated intracellular sodium concentrations produce increased intracellular 
calcium  concentrations  via  a  sodium  (Na+)  –  calcium  (Ca2+)  exchanger.  Excessive 
intracellular  calcium  is  concentrated  in  the  sarcoplasmic  reticulum  and  released  in 
excess, with depolarization18.
Release of excessive calcium results in enhanced cardiac contractions, which are 
delayed  after  depolarization  and  manifest  clinically  as  after  contractions,  such  as 
premature  ventricular  contractions.  Cardiac  glycosides  also  have  vagotonic  effects, 
resulting  in  bradycardia  and  heart  blocks.  Inhibition  of  Na+-K+-ATPase  in  skeletal 
muscle results in increased extra cellular potassium and contributes to hyperkalaemia18. 
Severe  hyperkalemia  can  contribute  to  atrioventricular  (AV)  block  and  depressed 
myocardial excitablity19. 
Cardiac glycosides primarily affect cardiovascular and gastrointestinal systems, of 
which  effects  on  the  cardiac  system are  most  significant.  The  pathophysiology  that 
produces  cardiotoxicity  involves  prolonging  refractory  period  in  the  atrioventricular 
(AV)  node,  shortening  refractory  periods  in  the  atria  and  ventricles,  and  decreasing 
resting membrane potential (increased excitability). Any dysrhythmia characterized by 
both increased automat city and depressed conduction is suggestive of cardiac glycoside 
toxicity18.
Dysrhythmias  often  associated  with  cardiac  glycoside  toxicity  include 
bradydysrhythmias,  sinus  bradycardia  with  all  types  of  atrioventricular  (AV)  nodal 
block,  junctional  rhythms and sinus  arrest.  Dysrhythmias  characterized  by  increased 
automaticity  and  conduction  blockade,  are  highly  suggestive  of  cardiac  glycoside 
toxicity.  These  include  tachydysrhythmias  such  as  atrial  tachycardia  with  block, 
paroxysmal  atrial   tachycardia  with  block,  bidirectional  ventricular  tachycardia  and 
ventricular fibrillation18.
Thevetin is easily  absorbed from the gastrointestinal  tract.  Thevetin glycosides 
occur in higher concentrations in heart muscle than in blood20. Thevetin probably has a 
shorter half-life than digoxin and a lower risk of accumulation in the body17.
Fatal dose
The kernals of the seed are most toxic with the reported lethal dose being 8-10 
seeds 5,29. Recent studies in Srilanka involving larger number of patients found that there 
was no exact relationship between number of seeds ingested and outcome4.
Clinical features of yellow oleander poisoning 
Symptoms
Closely resembles digitalis poisoning with gastrointestinal and cardiac symptoms.
Gastrointestinal symptoms 
Symptoms are nonspecific and include nausea, vomiting, diarrhea and abdominal 
pain 2,3.
Cardiac symptoms 
Include palpitations, shortness of breath, giddiness etc18.
Neurological Symptoms
Pupils  may  be  dilated21.  and  excessive  salivation  has  been  reported20. 
Paraesthesias and weakness have also been reported20. Symptoms are often nonspecific 
and include giddiness, numbness (especially of tongue and oral mucous membranes), 
altered  mental  status  (eg.  Disorientation,  confusion,  drowsiness,  lethargy  etc)  and 
occasionally seizures18.
Complications
1. Cardiogenic shock can develop secondary due to arrhythmias. The  various 
arrhythmias that are noted in yellow oleander poisoning are sinus bradycardia, 
sino-atrial block, all types of atrioventricular (AV) block including Mobitz type 
II second degree AV Block, junctional rhythm, supraventricular tachycardia, 
atrial  fibrillation,  artrial  flutter,  bundle  branch  block,  ventricular  ectopics, 
ventricular tachycardia and ventricular fibrillation8.
2. Hyperkalemia is seen in severe cases of yellow oleander poisoning8.
3. Acute renal failure can develop secondary to cardiogenic shock. 
4. Acid base disturbance-circulatory collapse can cause metabolic acidosis. 
Postmortem Appearance
              Subendocardial and perivascular hemorrhage with focal myocardial  
edema has been noted7. Generalised hemorrhages and signs of gastrointestinal irritation 
have also been found5.
Course and prognosis
In severe poisoning diarrhea, vomiting, abdominal pain and sinus bradycardia are 
early features. Hyperkalemia, conduction block and ventricular ectopics indicate serious 
toxicity20. Indicators of a poor prognosis include multiple and varying cardiac rhythms, 
with sino-atrial and atrioventicular blocks in combination with ventricular excitability, 
ST depression over 2.5mm and unresponsiveness to atropine2.  Conduction block and 
sinus bradycardia may persist for 5 days after ingestion. Patients usually recover from 
these if no underlying cardiovascular pathology exist20.
Management
 Investigations
Blood glucose estimation assess for hypoglycemia  as a possible cause of altered 
mental status, electrolyte disturbances. Management is very similar to that of digoxin 
poisoning. 
Decontamination
If consciousness is not impaired, emesis can be induced or gastric lavage can be 
performed.  Gastric  lavage  is  most  useful  when  started  within  sixty  minutes  after 
ingestion24.
Activated Charcoal 
Activated  charcoal  can  be  given  60-100g  orally  or  via  gastric  tube  mixed  in 
aqueous slurry24. Multiple doses of activated charcoal (50g of activated charcoal every 6 
hrs  for  3  days)  has  been  found  to  be  more  effective  in  reducing  deaths  and  life-
threatening cardiac arrhythmias after yellow oleander poisoning than single dose. After 
absorption  into  the  systemic  circulation  cardiac  glycosides  are  secreted  into  the  gut 
lumen  by  the  action  of  p-glycoprotein  (enterohepatic  circulation).  In  gut,  activated 
charcoal binds the secreted glycoside and encourages further secretion, thereby causing 
a rise in glycoside excretion. Through the interruption of the enterohepatic circulation of 
the  cardiac  glycosides  in  yellow  oleander,  multiple  doses  of  activated  charcoal 
administration improves outcome in yellow oleander poisoning9.
Electrolytes 
Hyperkalemia  occurs  in  severe  yellow  oleander  poisoning.  The  degree  of 
hyperkalemia  correlated  with  the  serum  digoxin  cross  reactive  cardiac  glycoside 
concentration8. Severe hyperkalemia can contribute to atrioventricular (AV) block and 
depressed myocardial excitablility19. Hypokalemia can also exacerbate cardiac glycoside 
toxicity  due  to  enhanced  binding  of  cardiac  glycoside  to  Na+-K+ ATP ase  pump22. 
Electrolytes  should  be  monitored  frequently,  particularly  serum  potassium  levels. 
Hypercalcemia and hypomagnesmia also can exacerbate cardiac glycoside toxicity. 
Blood urea and Creatinine. 
Acute  renal  failure  can  develop  secondary  to  cardiogenic  shock.  Renal 
insufficiency  is  associated  with  elevated  endogenous  digoxin  like  immunoreactive 
factors that can give false – positive digoxin assay results18. Renal function has to be 
closely monitored. 
Cardiac glycoside level. 
Some  plant  glycosides  cross  react  with  commonly  used  digoxin 
radioimmunoassay and digoxin fluorescence polarization immunoassays23.  Detectable 
levels  of  cardiac  glycosides  have  been  associated  with  ingestion  of  foxglove  and 
oleander ; however levels do not correlate with severity of illness, Beyond its qualitative 
usefulness in oleander toxicity, however the digoxin serum levels clinical significance is 
unknown.  Negative  digoxin  radioimmunoassay  does  not  rule  out  a  plant  glycoside 
exposure18. In one of the Srilankan studies there was a correlation between degree of 
hyperkalemia and the serum digoxin cross reactive cardiac glycoside concentration. But 
they  could  not  identify  cardiac  glycoside  levels  or  hyperkalemia  at  presentation  as 
determinants of mortality8.
Electrocardiogram (ECG) and continuous cardiac monitoring
To  find  out  the  cardiac  rhythm,  identify  life  threatening  arrhythmias  and  for 
treatment. 
Hemoglobin level – To determine if anemia is a cause or potential complicating 
factor for dysrhythmia or hypotension. 
Arterial blood gas analysis – To identify metabolic acidosis which may develop 
secondary to circulatory collapse. 
Sample collection – Remaining parts of the ingested plant and gastric contents are 
useful for botanical identification. Plant portions found in vomitus should be stored in a 
plastic bag for forensic examination. 
Treatment
General principles include providing general supportive care, immediate gastric 
decontamination, preventing further exposure and absorption, administering antidote and 
correction of arrhythmias and electrolyte imbalances.
Antidote 
Anti-digoxin Fab fragments are a safe and effective treatment for serious cardiac 
arrhythmias  induced,  by  yellow  oleander10.  The  investigators  used  1200mg  of 
antidigoxin  Fab  fragment  in  a  randomized  controlled  trial  involving  66  patients. 
Flanagan RJ and Jones AL recommend that the approximate dose of Fab fragments (mg) 
is 80 times the digoxin body burden (mg). They recommend a dose of 380mg of anti-
digoxin Fab fragment in an adult if neither the dose for elderly patients nor those with 
renal impairment should be similar to that for those with normal renal function. The 
antibody fragments are given intravenously over 15-30 minutes after dilution to at least 
250ml with  0.9% (w/v) sodium chloride. Fab fragments are generally well tolerated. 
Adverse effects include hypokalemia and exacerbation of congestive cardiac failure ; 
renal  function  could  be  impaired  in  some  patients25.   Indications  of  use  include 
hyperkalemia  (>5.0meq/1),  life-threatening  supraventricular  and  ventricular 
dysrhythmias and hemodynamically significant bradycardia unresponsive to atropine18.
Treatment of Arrhythmias
Since onset of action of Fab fragments may take 30-60min, intervening treatment 
of significant complications should be done. 
Bradyarrhythmias
Atropine  and  cardiac  pacing  can  be  tried.  Patients  requiring  transcutaneous 
cardiac pacing should receive Fab fragments prior to it. Transvenous pacing and use of 
isoproterenol  can  result  in  degeneration  of  cardiac  rhythm and  should  be  avoided. 
Overdrive pacing should not be used for the control of ventricular dysrhythmias18.
Tachyarrhythmias
Phenytoin and lidocaine are agents of choice. Magnesium has been reported to 
reverse digoxin induced dysrhythmias and may be useful as long as anuric renal failure 
is not present. Quinidine and procainamide may enhance cardiac glycoside toxicity by 
slowing conduction across AV node ; both should be avoided18.
Cardioversion is  used as a  last  resort,  as  it  may induce intractable  ventricular 
fibrillation.  Fab  fragments  should  be  given  with  cardioversion.  If  time  permits, 
cardioverison  should  be  attempted  after  a  loading  dose  of  phenytoin  and  at  a 
significantly reduced initial power setting of 5-10J18.
Hyperkalemia                                                                                                Glucose, 
insulin, sodium bicarbonate and salbutamol may be used to facilitate redistribution of 
potassium intracellularly.  However,  salbutamol may precipitate cardiac dysrhythmias. 
Life threatening hyperkalemia should  be treated with Fab fragments. Calcium should be 
avoided in hyperkalemia due to cardiac glycoside toxicity as already there is excess of 
calcium intracellularly and results in overloading of myocytes with calcium, increased 
dysrhythmias, and a higher rate of death18.
Cardiac arrest
Give 10-20 vials of  Fab and treat with standard advanced cardiac life support 
(ACLS)  principles.  Prolonged  efforts  at  resuscitation  may  be  warranted  until  Fab 
fragments begin to work18.
Elimination
Forced diuresis, hemoperfusion and hemodialysis are ineffective in enhancing the 
elimination of cardiac glycosides due to their large volume of distribution. Hemodialysis 
will efficiently remove potassium from extracellular fluid18.
Analysis of published Indian reports.
Analysis  of  300 patients  of  yellow oleander  poisoning studied  in  BS Medical 
College, Bankura from 1986 to 1990 showed the following. 
- Majority i.e., 246 (82%) were females. 226 (75.33%) young in the age group (11-
20 years). Delay in taking treatment was between 6 to 8 hrs. Number of seeds 
ingested varied from ½ to fifteen 97.33% had vomiting and 12% had palpitation. 
138(46%) revealed various Arrhythmias.  Sinus bradycardia in 68 cases and ST-T 
changes  present  in  39.33%.   Number  of  seeds  ingested  did  not  bear  any 
relationship with ECG changes.  
Analysis  of  clinical  profile  of  32  cases  of  yellow oleander  poisoning  at  VSS 
Medical College, Burla. Majority were females in the age group 16-20 yrs.  Symptoms 
were vomiting in 46.9% of cases, numbness sensation in 43.8, dryness of mouth in 25%, 
diarrhea in 18.8% of cases.  Routine blood and urine examination were within normal 
limits.  There was no biochemical  abnormalities detected.  The ECG change noted were 
sinus bradycardia in (53%), 1 AV block in 5 (15.6%), III AV block in 1 (3.1%), ST 
elevation in 2 (6.2%), ST depression in 4 (12.5%) and T wave changes in 6 (18.8% of 
cases).
MATERIALS AND METHODS
Setting
Department  of  Medicine,  Coimbatore  Medical  College  Hospital,  Coimbatore. 
There was no other collaborating department.  
Design of Study
Prospective study
Period of study
January 2007 to August 2008
Sample size
Hundred and six cases of yellow oleander poisoning that satisfied the inclusion 
and exclusion criteria.
Selection of study subjects
Yellow oleander poisoning cases who fulfilled the inclusion and exclusion criteria.
Inclusion criteria
                Those admitted in general medicine wards with history of yellow oleander 
ingestion during the period of  January 2007 to August 2008. 
Exclusion criteria
1. Paediatric cases were excluded (<13yrs of age)
2. Those with underlying severe cardiac, renal or hepatic disease were excluded.
3. Patients who were taking the following drugs were excluded – Digoxin , Diuretics 
, Verapamil , diltiazem , Beta blockers, ACE inhibitors, Amiodarone, calcium and 
potassium supplements were excluded.
Methods
Selected  sociodemographic,  clinical,  biochemical,  electrocardiographic  and  treatment 
details were collected from the patients and recorded in a proforma. 
Socio demographic data consisted of 
- Age
- Sex
- Locality
- Occupation
- Income
Data regarding poisoning comprised of part ingested, quantity of poison, method 
of ingestion, whether consumption in empty stomach or after food, the intention behind 
poisoning,  time  of  ingestion,  first  aid  at  home,  consumption  to  admission  interval, 
treatment  given, duration of hospital stay and the type of outcome.  
Clinical data comprised of 
Symptom analysis, pulse rate, rhythm, blood pressure and systemic examination.
Laboratory data included
- Blood sugar
- Blood Urea
- Serum Creatinine
- Serum Na +, K+,  values
- Electrocardiogram (ECG)
Blood urea, sugar, serum creatinine and serum Na  +, K+, values were estimated 
using ERBA XL 300 automated analyzer. The blood urea, sugar, creatinine and serum 
Na +, K+, were measured at the time of admission before instituting  treatment.  12 lead 
ECG, including rhythm strip in lead 11  and V1 was taken in all patients. 12 lead ECG 
including rhythm strip was taken at admission before instituting treatment and repeated 
depending on the clinical status. 
Ethical committee approval 
The present project was approved by the ethical committee. 
Consent 
An informed consent was obtained from all patients who were included in the 
study. 
Limitations 
1. Continuous ECG monitoring and serial  levels  of  electrolytes like serum 
potassium  and sodium could not be done due to technical constraints. 
2. Estimation of cardiac glycoside level was not done due to nonavailability 
and financial constraints. 
3. Activated charcoal, anti-digoxin Fab fragments were not administered and 
temporary pacemaker not used due to financial and technical constraints. 
4. Arterial  blood  gas  analysis  was  not  done  due  to  nonavailability   and 
financial constraints.
Conflicts of interest 
There was no conflict of interest. 
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Statistical analysis 
Data  were  entered  in  Microsoft  Excel  spreadsheet  and  analyzed  utilizing  the 
software – Epidemiological Information Package 2002 (Epi Info 2002) – developed by 
the Centre for Disease Control and Prevention, Atlanta for World Health Organization, 
Frequencies,  percentages,  range,  mean,  standard  deviation  and  ‘p’  values  were 
calculated using this package. 
  Chi  Square test  was done to  find out  the significance of  relationship between the 
groups.  SPSS software  was  used  for  analysis.  The  difference  was  considered  to  be 
significant if the ‘p’ value was less than 0.05.
                                                        RESULTS
Incidence of Yellow Oleander Poisoning
The incidence of yellow oleander poisoning among total number of admissions in 
general medicine wards of Coimbatore Medical college Hospital,  Coimbatore, during 
the study period was 11.8 per1000admissions. It accounted for 95.8% of the cases of 
plant poisoning. In general, 10% of the cases among the total number of admission in 
general medicine wards were poisoning cases. Among the poisoning cases, 86.7% were 
chemical poisoning and 13.3% plant poisoning. Among the total number of poisoning 
cases, yellow oleander accounted for 12.7% of the cases. This is explained using a flow 
chart. 
Poisoning Cases – 911 
Chemical – 790 (86.7%) Plant – 121 (13.3%)
Yellow Oleander – 116 (95.8%) Other-10 (4.2%)
Distribution of cases in relation to age. 
The maximum number of cases occurred in the age group 20-29 (42.5%) followed 
by age  group 13-19 (30.2%) and 30-39 (17%) respectively.  The age of  the patients 
ranged  from 13-62  years.  The  mean  age  and  standard  deviation  was  27+ 10.  The 
differences in the mean age of males and females were not statistically significant. The 
group gives the distribution of cases according to age group and gender. (Figure 1)
Table no: 1       Age group distribution 
Age (in 
years)
               Sex of the patient
       males      females
percentage
12.3%
18.9%
10.4%
4.7%
percentage
17.9%
23.6%
6.6%
5.7%
<20
20-29
30-39
>39
Distribution of cases in relation to gender 
Among the  total  of  106  cases,  49  (46.2%)  were  males  and  57  (53.8%)  were 
females (Figure 2). The ratio of females: males were 1.16:1, but the difference was not 
statistically significant (P > 0.1). 
Table no: 2 Distribution with regard to gender
Sex of the patient count percentage
male
    49    46.2%
female
   57     53.8%
Distribution of cases in relation to income 
77.3% of the patients had income below Rupees two thousand per month. The 
mean income was Rupees 1603 + 3315 range being                  Rs. 200 – 30,000. The 
details are given in the table below.
          Table No.3 Distribution of cases in relation to income
Income ( in rupees) counts percentage
<1000 28 26.4%
1000-1999 23 21.7%
2000-2999 10 9.4%
3000-3999 5 4.7%
>4000 9 8.5%
No income 31 29.2%
Intention behind poisoning 
        The intention behind poisoning was suicidal in majority of cases (81.1%) and 
accidental in 1.9% (figure 4). In 17% of cases the poisoning attempt was done just to 
frighten others for some personal gain or to resolve conflict. There were no cases of 
homicidal poisoning.
                      Table No.4 Intention behind poisoning
Intention counts percentage
suicidal 86 81.1%
accidental 2 1.9%
homicidal 0 0%
others 18 17.0%
Figure 2           Sex incidence
 Figure 1 - Age Distribution
Time of ingestion 
 In majority of cases (84.9%) the poisoning between  6 am  - 6 pm. (figure – 5)
                                Table no.4      Time of ingestion
Time in hours Persons  consumed percentage
6am- 6pm 90 84.9%
 Figure 4 -   Intention behind poisoning
Figure 3 -       Income ( in Rupees)
After 6pm 16 15.1%
  Electrocardiographic manifestations of yellow oleander poisoning. 
The most common abnormal findings were sinus bradycardia (34%) and   ST – T 
changes (40.6%) (Which were similar to that described for digoxin effect / toxicity). 
Third – degree AV block and first – degree AV Block were noted in 7 cases each. Mobitz 
type – II second degree AV block which is not described in digitalis toxicity occurred in 
two cases. Depending on the ECG changes, all cases of yellow oleander poisoning were 
divided  into  no,  less  severe  and   severe  cardiotoxicity  groups(  No  cardiotoxicity 
includes  those  presenting  with  sinus  rhythm  and  sinus  tachycardia,  less  severe 
cardiotoxicity includes those with sinus bradycardia, atrial ectopics,ST-T changes,first 
degree  heart  block.  Severe  toxicity  includes  junctional  rhythm,  second  degree  heart 
block, third degree heart block and AV dissociation).Figure 8.
Table No.5 ECG changes in yellow oleander poisoning
   ECG manifestations count percentage
No cardiotoxicity sinus rhythm 64 60.4%
sinus tachycardia 12 11.3%
 Less severe cardiotoxicity sinus bradycardia 36 34.0%
atrial ectopics 1 0.9%
first degree heart block 7 6.6%
ST- T changes 43 40.6%
Severe cardiotoxicity junctional rhythm 3 2.8%
second degree heart block 2 1.9%
AV dissociation 2 1.9%
third degree heart block 7 6.6%
                              Effect similar to Digitalis 
 Figure - 5        Time of ingestion
                                            First Degree Heart Block
 Figure 7     ECG changes
                                                AV dissociation
In majority of the cases (44.8%) some form of the cardiotoxicity was present. Severe 
cardiotoxicity was present in about 19% of the cases. The details are depicted below in 
the table and the pie diagram(figure- 8). 
                                          Table no.6        Cardiotoxicity
   Cardiotoxicity count Percentage
No cardiotoxicity 38 36.2%
Less severe cardiotoxicity 47 44.8%
Severe cardiotoxicity 20 19.0%
Relationship between part ingested and cardiotoxicity
Majority of the patients had taken either  the fruit  or  seed,  55 and 51 patients 
respectively  .  There  was  no  statistically  significant  difference  in  the  cardiotoxicity 
caused by fruit and seed (p>.05). The details are given in the table given below and 
figure 9. 
 Table No. 7 Part ingested and Cardiotoxicity
Parts of 
plant
                                cardiotoxicity
No 
cardiotoxicity
Less severe 
cardiotoxicity
Severe 
cardiotoxicity
Count    % Count     % Count     %
fruit 19 34.5% 25 45.5% 11 20.0%
seed 19 38.0% 22 44.0% 9 18.0%
Flower - - - - - -
leaves - - - - - -
Roots - - - - - -
others - - - - - -
Figure 8 Cardiotoxicity
Relationship between quantity of poison ingested and cardiotoxicity
The mean number of seeds / fruits ingested in no cardiotoxicity group was 2 and 
that  in  less  severe  Cardiotoxicity  group  was  4.  The  difference  was  statistically 
significant (p=0.001). The range, mean and standard deviation of quantity of poison in 
each of the groups is depicted in table 8. 
Table No. 8 Quantity of poison ingested and cardiotoxicity
Cardiotoxicity Range Mean Standard Deviation
No Cardiotoxicity` 1-5 2 1
Less severe Cardiotoxicity 1-10 4 4
Severe Cardiotoxicity 1-18 3 1
Relationship between method of ingestion of poison and cardiotoxicity
 59.6% of those who had taken the poison in the crushed form had less severe 
cardiotoxicity  compared  to  31%  in  those  who  had  taken  the  poison   chewed. 
Cardiotoxicity  were  more  observed  in  those  who  took  in  a  crushed  form and  this 
difference was statistically significant at p = <0.05. The details are shown in the table 
below and Figure 10
             Table No. 9 Method of ingestion and cardiotoxicity
                                            Cardiotoxicity
No cardiotoxicity  Less severe 
cardiotoxicity
Severe 
cardiotoxicity
Count  N % Count N % Count  N %
crushed 11 21.2% 31 59.6% 10 19.2%
chewed 20 47.6% 13 31.0% 9 21.4%
swallowed 7 70.0% 2 20.0% 1 10.0%
others - - - - - -
Figure 10  Method of ingestion
Figure 9-     Part ingested and Cardiotoxicity
Relationship between manner of consumption and Cardiotoxicity 
60.4% of the patients had consumed the poison in empty stomach and the rest 
after food. 47.7% of the patients who had taken the poison in empty stomach had some 
form of cardio toxicity compared to 16.2% in patients who took the poison after food. 
The difference between the groups was statistically significant (p<0.05). The details are 
shown in the graph and the table given below. 
Table No. 10 Manner of consumption and cardiotoxicity
Manner of 
consumption No 
Cardiotoxicity
Less severe 
cardiotoxicity
Severe 
cardiotoxicity
No % No % No %
In empty
Stomach
17 16.2% 35 33.3% 15 14.3%
After food 
21 20.0% 12 11.4% 5 4.80%
Relationship between first aid and cardiotoxicity
Majority were not given first aid (57.7% of cases). 59.6% of patients who 
were  given  first  aid  developed  some  form of  cardiotoxicity  compared  to  63.5% in 
patients who were not given first aid. (This refers to method adopted by local people to 
bring out the poison.  The method mostly used was to induce vomiting using salt water, 
tamarind water, soap water etc). The difference between the groups was not statistically 
significant (p=0.8529) The details are given in the table below and Figure 11
         Table No. 11 First aid and cardiotoxicity
Relationship between time of first aid and cardiotoxicity
In patients who were given first aid 2 hrs after consumption of poison, all of them 
developed cardiotoxicity compared to 55% in patients who were given first aid within 
one hour. The difference between the groups was not statistically significant (p=>0.05) 
The details are given in the table below and explained using a graph(figure 12). 
Table No.12  Time of first aid and cardiotoxicity
Time in 
minutes
                            cardiotoxicity
  no Less severe severe
Count percentage Count percentage Count percentage
1 to 60 9 45.0% 6 30.0% 5 25.0%
61 to 120 0 0% 2 66.7% 1 33.3%
>120 0 0% 5 83.3% 1 16.7%
First aid Cardiotoxicity
No 
Cardiotoxicity
Less severe 
cardiotoxicity
Severe
cardiotoxicity 
No % No 42.5 No %
Given
13 12.4 21 20.0 9 8.6
Not 
Given
25 23.8 26 24.8 11 10.5
Relationship between consumption to admission interval and cardiotoxicity
The mean delay in getting to Coimbatore Medical College Hospital, Coimbatore 
after consumption of poison was 12.5+5.6hrs, the range being 1-62 hrs. The mean delay 
in  no,  less  severe  and  severe  cardiotoxicity  group was  13.32,  12.25,  and 12.36  hrs 
respectively. The difference between the groups was not statistically significant.
 Figure 12-Time of First Aid
Figure 11  First Aid
Relationship between symptoms and cardiotoxicity 
The  most  common  symptoms  of  yellow  oleander  poisoning  were  vomiting 
(72.6%), giddiness (56.6%) and diarrhea (35.8%).Approximately 75% of the patients 
who had at least two symptoms or all the three symptoms had features of cardiotoxicity. 
The difference between the groups was statistically significant (p=0.0005). The details 
are shown in the tables given below ( table no. 13) 
             Table No.13 Symptoms of yellow oleander poisoning
Symptoms No %
Vomiting 77 72.6
Abdominal pain 16 15.1
Diarrhea 38 35.8
Giddiness 60 56.6
Numbness  of  tongue  & 
lips
0 0
Altered mental status 0 0
Blurred vision 21 19.8
Palpitation 25 23.6
Shortness of sheath 8 7.5
                 
                  Table No.14  Symptoms and cardiotoxicity
           symptoms                                             cardiotoxicity
No Less severe severe
Count % Count % Count  %
vomiting 22 21.0% 38 36.2% 16 15.2%
abdominal pain 6 5.7% 5 4.8% 4 3.8%
diarrhoea 7 6.7% 20 19.0% 10 9.5%
giddiness 17 16.2% 31 29.5% 11 10.5%
numbness of lips and 
tongue
0 0% 0 0% 0 0%
altered mental status 0 0% 0 0% 0 0%
blurring of vision 4 3.8% 10 9.5% 7 6.7%
palpitation 4 3.8% 11 10.5% 10 9.5%
shortness of breath 1 1.0% 4 3.8% 3 2.9%
Vital signs and biochemical parameters 
The range, mean and standard deviation values of pulse rate, blood pressure and 
biochemical  parameters  are  given  in  the  table  no.15.  The  mean  values  of  all  these 
parameters were within normal limits. Pulse rate was irregular at admission in 15.1% of 
the cases; in the rest the pulse rate was regular. Hypotension was present in two cases at 
admission. 
               
  
 Table No. 15 Vital signs and biochemical parameters
Parameter Range Mean S.D
Pulse rate at admission 36-140 80 20
Systolic  blood  pressure  (mm 
Hg)
70-150 112 14
Diastolic  blood  pressure 
(mmHg)
40-100 74 10
Blood urea (mg/dl) 15-72 27.5 10.44
Blood sugar (mg/dl) 56-235 93 31
Serum Creatinine (mg/dl) 0.6-1.8 .89 0.19
Na (meq/l) 122-160 138 5
 Relationship between S.potassium  and cardiotoxicity 
The mean serum potassium values were higher in some (4.10 meq/l) and severe 
cardiotoxicity groups (4.10meq/l) compared to patients with no cardiotoxicity 
(3.9meq/I). There was a positive correlation between serum potassium levels and 
cardiotoxicity in the present study.  
Table No.16  Serum K+ levels in yellow oleander poisoning
S.potassium
                                         Cardiotoxicity
 no Less severe severe
Mean Standard 
Deviation
Mean Standard 
Deviation
Mean Standard 
Deviation
3.9 .4 4.1 .4 4.1 .4
Relationship between gastric lavage and cardiotoxicity 
Gastric lavage was given in 89.2% of the cases. In those who were given gastric 
lavage, 33.3% did not develop any cardiotoxicity  compared to 2.9% in those who were 
not given gastic lavage. The difference between the groups was statistically insignificant 
(p=>0.05). The table below shows the details. 
Table No.17 Gastric lavage and cardiotoxicity
gastric 
lavage
given
not given
                          cardiotoxicity
no Less severe severe
Count  N % Count N % Count  N %
35 33.3% 42 40.0% 17 16.2%
3 2.9% 5 4.8% 3 2.9%
Figure 13-Symptom analysis
Treatment given in yellow oleander poisoning 
Most of the patients were given supportive treatment in the form of gastric lavage, 
injection atropine and tablet orciprenaline. Steroids were not used in any of the cases. 
Some  patients  were  given  tablet  salbutamol  and  tablet  deriphylline.  Few  patients 
received injection sodium bicarbonate. The details are given in the table given below. 
Table No.18 Treatment given in yellow oleander poisoning
No %
Gastric lavage 95 89.6
Injection atropine 76 71.7
Tablet orciprenaline 93 87.7
Steroids 0 0
Relationship between cardiotoxicity and duration of hospital stay
The mean duration of hospital stay was 5 days, range being 1-9 days. The mean 
duration  in  no,  less  severe  and  severe  cardiotoxicity  groups  was   4,  5  and  5days 
 Figure 14-Gastric lavage and Cardiotoxicity
respectively. The difference between the groups was statistically significant (p=0.0001). 
The details are given in the table below and explained using a graph. 
Table No. 19 Duration of hospital stay and cardiotoxicity
Duration of 
hospital stay
No 
Cardiotoxicity
Less severe 
cardiotoxicity
Severe
cardiotoxicity
Mean 4 5 5
S.D. 1 1 2
Range 1-9
Outcome
Out of 111 cases, 86.4% of the cases were discharged well. Death occurred in two 
cases (1.9%, one male and female patient) and 11.7% of the patients absconded from the 
wards. There was no statistically significant difference in outcome among males and 
females (p=0.7002)
Table No:20   Outcome
OUTCOME count percentage
improved 92 86.8%
expired 2 1.9%
AMA 0 .0%
absconded 12 11.3%
Relationship between cardiotoxicity and outcome
Out of 106 cases, only two deaths occurred. The deaths occurred in patients who 
had severe cardiotoxicity. But there was no statistically difference in outcome among no, 
some and severe cardiotoxicity groups (p=>0.05)
                         Table No 21 Cardiotoxicity and outcome
outcome                             cardiotoxicity
  no Some severe
Count percentage Count percentage Count percentage
improved 29 44 18 29 44 18
expired 0 1 1 0 1 1
AMA 0 0 0 0 0 0
absconde
d
9 2 1 9 2 1
                                          
Figure 15-OUTCOME
                                                          DISCUSSION
Yellow oleander poisoning is a common method of deliberate self-harm among 
young adults in Srilanka and southern India. This study was done to find out the burden 
of this poisoning among admissions in general medicine wards of Coimbatore Medical 
College Hospital, Coimbatore, to analyse the clinical aspects, to correlate clinical and 
biochemical parameters with cardiotoxicity and to identify the possible risk factors for 
cardiotoxicity and outcome. 
The incidence of yellow oleander poisoning among total number of admissions in 
general  medicine  wards  of  our  hospital  during  the  study  period  was  11.8  per  1000 
admissions. Though it has been mentioned in previous studies that thousands of cases 
occur in Srilanka every year4, the exact incidence in a particular population has not been 
previously  reported.  Among  the  total  number  of  poisoning  cases,  yellow  oleander 
accounted for 12.7% of the cases.
Among the 106 cases studied, the mean age of patients was 27+/ 10 years, range 
being 13-62 years (pediatric cases not included). 72.7% of the cases occurred in the age 
group  between  13-29  years.  This  observation  confirms  the  observation  of  previous 
Indian  and  Srilankan  studies  that  yellow  oleander  poisoning  was  found  commonly 
among adolescents and young adults4,7.  Eddleston M et al, in a study of 415 cases in 
Srilanka observed that the patients were young (mean age 25.8 years, range 11-71). In 
that study more than 50% of women and 35% of men were under 21 years4. 49 (40.05%) 
were males and 57 (54.95%) were females. The ratio of  females: males was 1.16:1
          Regarding the sex distribution 53.8% of the cases were females and 46.2% cases  
were males, the ratio being 1.16:1. In the present study there was only a slight female 
preponderance when compared to findings of  previous Indian and Srilankan studies. 
Eddleston  M et al, observed a  female : male ratio of 1.6:1 in his study involving 415 
patients in srilanka4.  Generally this poisoning was found to be more common among 
females when compared to males4,7,25.
Majority of the patients belonged to the upper lower and lower socioeconomic 
class  (Kuppuswami,  1962  (modified))  77.3% of  the  patients  who were  earning  had 
income below Rupees two thousand per mth. The mean income was Rupees 1603 and 
majority were daily wage labourers.
75% of the patients were from the rural areas probably due to the fact that the 
plant can be easily found and widely grown in rural areas. There was no expenditure of 
money in consuming the poison and for many patients this was only poison known to 
them. 
Most of the cases occurred during the working hours 6am – 6pm (84.9%) when 
the relatives were away for work or the victims have consumed the poison near their  
workplace. 
The  intention  behind  the  poisoning  was  suicidal  in  81.1%  of  the  cases.  The 
reasons  included  interpersonal  conflict,  unemployment,  failure  to  achieve  goal, 
situational  reaction,  grief  reaction,  physical  illness  etc.  Two  patient  had  underlying 
psychiatric illness and was on antipsychotic drugs. In 17% of the patients, poisoning 
attempt was done just to frighten others for some personal gain or to resolve conflicts. 
There were two cases of accidental poisoning among adolescents. There were no cases 
of homicidal poisoning probably due to the bitter taste of the poison. The observations 
regarding the intention behind poisoning were similar to that observed by Eddleston M 
et al4.
Regarding underlying illness, except for three patients which includes two cases 
of psychiatric illness, one case of hypertension, none had any previous illness. Both of 
these patients were on irregular treatment. Three of the female patients were pregnant 
while consuming the poison and all of them recovered. This was similar to the findings 
observed by Eddleston M et al, who noted that only one patient had underlying illness 
(rheumatic  heart  disease)8.  This  observation  differed  markedly  from  patients  with 
digoxin poisoning. Many of the patients with digoxin poisoning had underlying heart 
disease and were on multiple drugs.27. This observation is important because as a result 
of young age and previously healthy state, the cardiac arrhythmias induced by yellow 
oleander poisoning are unlikely to result from pre-existing conditions. 
The electrocardiographic changes that were noted in this study was mainly due to 
depressed  conduction.  Most  common  abnormalities  were  sinus  bradycardia,  ST-T 
changes suggestive of digoxin effect  toxicity,  first-degree AV block,  third-degree AV 
block and sino-atrial block. Others included second-degree AV block, junctional rhythm, 
AV dissociation and atrial ectopics. The observations were similar to that of Eddleston 
M  et  al  except  that  tachyarrhythmias  (0.5-1%)  like  atrial  flutter,  atrial  fibrillation, 
ventricular tachycardia and ventricular fibrillation observed by Eddleston  M et al were 
not  observed  in  the  present  study.  In  the  same  study  3-6%  had  supraventricular 
tachycardia  and 2% had ventricular  ectopics which was not  observed in  the present 
study8.  Mobitz  type – II  second-degree AV block which is  not  described in digoxin 
toxicity  occurred in  two cases28.  In  yellow  oleander   poisoning arrhythmias due to 
depressed conduction were more common than tachyarrhythmias and thus differs from 
digoxin poisoning in which tachyarrhythmias were found to be more common27.
Depending on the ECG changes patients were divided into no, less severe and 
severe  cardiotoxicity  groups  and  the  relationship  between  various  factors  and 
cardiotoxicity  was  studied  (Refer  definitions  in  materials  and  methods).  Majority 
(63.8%) of cases showed  some form of cardiotoxicity. Severe cardiotoxicity was present 
in approximately 19% of the cases. 
               The common method of poisoning in the present study was ingestion of fruits  
or  seeds  in  the  crushed  or  chewed form.  Three  patients  had  taken the  outer  fleshy 
covering of the nut and these patients had no cardiotoxicity. Toxicological studies in 
albino rats have shown that all parts of the plant were poisonous especially the seeds / 
kernels of fruit16.  Other parts like roots,  leaves or flowers were not taken. The mean 
number of seeds / fruits ingested in severe (3) and less severe cardiotoxicity groups (4) 
were higher than that in no cardiotoxicity group (2) The range in no, some and severe 
cardiotoxicity  groups  were  1-5,  1-10,  and  1-18  (seeds/fruits)  respectively.  Although 
there was a positive correlation between quantity of poison and cardiotoxicity in the 
present study it should be noted that even one seed / fruit was found to cause some or 
severe cardiotoxicity.  Relationship between quantity  of  poison and outcome was not 
present as only two deaths had occurred and patients who had taken six and ten seeds 
had all  survived. Two patients who died had consumed 5 and 18 seeds respectively. 
Eddleston M et al (1999) also observed no relationship with seeds ingested and outcome. 
In that study six patients who had died had consumed 10, 5,8,1,5 and 2 seeds4. So the 
quantity  of  poison  alone  cannot  determine  outcome,  it  may  be  influenced  by  other 
factors like method of ingestion, consumption in empty stomach or not, delay in gastric 
lavage, treatment given etc. 
Majority had taken the seeds / fruits in the crushed form. 59.6% of those who had 
taken the poison in the crushed form had less severe  cardiotoxicity compared to 31% in 
those  who  had  taken  the  poison   chewed,  which  shows   a  higher  incidence  of 
cardiotoxicity ( statistically significant) in those who had taken the seeds / fruits crushed 
compared to those who had chewed or swallowed the poison. This is probably due to the 
fact  that  more  amount  of  cardiac  glycoside  is  available  to  be  absorbed  once  the 
seeds/fruits are crushed and one patient developed severe cardiotoxicity. This finding is 
supported by the fact  that  in  srilanka  people usually  eat  the seeds whole  and they 
develop cardiotoxicity. So even the seeds taken as a whole can cause cardiotoxicity but 
to a lesser extent when compared to crushed or chewed form. The method of ingestion 
observed in the present study was similar to that reported in a study from Eastern India 
in which majority (97.33%) of the patients had ingested the poison in the crushed form7.
Most of the patients (60.4%) had consumed the poison in empty stomach. There 
was a higher incidence of cardiotoxicity in patients who had consumed the poison in 
empty stomach than after food. This is probably due to the fact that absorption of cardiac 
glycoside  is  better  in  empty  stomach.  In  previous  studies  this  relationship  was  not 
assessed. 
In 57.7% of cases first aid was given at home after the ingestion of poison. The 
commonly used method was to induce vomiting using soap water, tamarind water, salt 
water  etc.  There was no statistically  significant  difference  in  cardiotoxicity  between 
patients who were given first aid and those who were not given first aid. This is because 
of the fact that in many patients there was a delay in giving first aid. But in patients who 
were given first aid, delay in giving first aid was associated with increased incidence of 
cardiotoxicity.  So  bringing  out  the  poison  early  before  the  poison  has  passed  into 
intestine  reduces  the  incidence  of  cardiotoxicity  in  yellow  oleander  poisoning.  The 
relationship between time of first  aid and cardiotoxicity was not studied in previous 
reports. 
The mean delay in getting admitted to Coimbatore Medical College, Coimbatore 
after consumption of poison was 12.5+5.6 hrs, the range being 1-62 hrs. A correlation 
between  delay  in  getting  admitted  to  our  hospital  and  cardiotoxicity  could  not  be 
obtained probably due to the fact that many patients were given first aid and treated 
outside in other hospitals/institutions before being referred to our hospital. Bose TK et al 
(1999) observed a delay of 6-8 hrs7. The reasons for the delay in getting to our hospital 
in the present study would be treatment of patients outside by others doctors and lack of 
adequate transportation in interior rural areas. In patients with high suicidal intent the 
relatives come to know of the poisoning only after several hours and this night have 
contributed to the delay. 
The most common symptoms of yellow oleander poisoning in the present study 
were vomiting (72.6%), giddiness (56.6%) and diarrhea (35.8%). This was similar to 
findings noted by Saravanapavanathan N and Ganeshmoorthy J (1986) who observed 
vomiting, giddiness and diarrhea as the most common symptoms in their study of 170 
cases in Srilanka2.  Patients  who had vomiting,  diarrhea or  altered mental  status had 
higher incidence of cardiotoxicity compared to those who did not have nay one of the 
above  symptoms.  Among  patients  who  had  at  least  two  or  all  the  three  of  above 
symptoms 75% developed cardiotoxicity. Thus patients with either vomiting, diarrhea or 
altered  mental  status  should  be  closely  monitored  for  cardiotoxicity.  Ellenhorn  and 
Barceloux (1988) have also noted that in severe poisoning diarrhea and vomiting are 
early features20.
The average pulse rate at admission was 80+20 per minute, range         being  36-
140 per minute. Many patients had a normal pulse rate and rhythm at admission only to 
develop features of cardiotoxicity later usually within a day. 
Eddleston M et al (1999) have described a patient who remained in sinus rhythm 
for three days before developing second degree AV block4. So patients may have to be 
observed for 3-4 days after ingestion of poison before being discharged home. 
Hyperkalemia occurs in severe yellow oleander poisoning8. Severe hyperkalemia 
can contribute to atrioventricular (AV) block and depressed myocardial excitability19. In 
the present study hyperkalemia was noted in only two our of 97 cases (2.1%) in whom 
the  serum  potassium  levels  were  measured.   Both  of  these  patients  had  some 
cardiotoxicity.   But  there  was  a  correlation  between  serum  potassium  levels  and 
cardiotoxicity in the present study.  The mean serum potassium values were higher in 
some (4.10 meq/l) and severe cardiotoxicity groups (4.10meq/l) compared to patients 
with no cardiotoxicity (3.9meq/I). Eddleston M et al (2000) noted hyperkalemia in 38 
patients out  of  118 cases (32.2%). Very high values of potassium like 7.2meq/l,  8.4 
meq/l and 10.8 meq/l were observed in that study8. In the present study the two patients 
who had hyperkalemia had values of 5.5 and 5.2 meq/l.  The reason why hyperkalemia 
was not as common when compared to Srilankan study would be that poisoning might 
have been less severe or due to the persistent vomiting due to poisoning per se or due to  
induced emesis.  Another reason would be that serial serum potassium measurements 
were not obtained due to technical constraints and hyperkalemia developing during the 
course  of  poisoning  was  missed  (serum  potassium  levels  were  measured  only  at 
admission).  Moreover  the  baseline  potassium  level  in  the  population  also  was  not 
known. Hypokalemia was noted in 6 of our cases.  Eddleston M et al, (2000) noted 
hypokalemia in 9 out of 118 cases8. Hypokalemia may be probably due to persistent 
vomiting  due  to  poisoning  per  se  or  due  to  induced  emesis.   Hypokalemia  can 
exacerbate  cardiac  glycoside  toxicity  as  if  facilitates  enhanced  binding  of  cardiac 
glycosides  to  Na+ -K+ ATPase  pump22.  Both  hyperkalemia  and  hypokalemia  are 
dangerous in yellow oleander poisoning and serial monitoring of potassium levels and 
adequate  treatment  is  necessary.   Severe  hyperkalemia  may  require  treatment  with 
antidigoxin Fab fragments18. 
There was no statistically significant difference in cardiotoxicity between patients 
who were given gastric lavage and those who were not given gastric lavage.  Gastric 
lavage is  most  useful  when started within 60 minutes after  ingestion24.  Early gastric 
lavage is more important than whether gastric lavage is given or not in reducing the 
incidence of cardiotoxicity.  This relationship was not assessed in previous published 
reports. 
                            Most of the patients were treated with supportive measures like gastric  
lavage, injection atropine, tablet orciprenaline and none of the cases steroids were used. 
There are no scientific studies or trials to support the use of steroids in yellow oleander 
poisoning.  Activated charcoal, temporary cardiac pacing and antidigoxin Fab fragments 
were not used due to economical and technical constraints. 
The mean duration of hospital stay in the present study was 5 days, range being 1-
9 days.  Those patients with some and severe cardiotoxicity had increased duration of 
hospital stay when compared to patients with no cardiotoxicity.  This was similar to 
findings observed by Boss TK et al (1999) who observed a median hospital stay of 5 
days7. 
      Death occurred in two cases (one male and female patient) within one hour after 
admission. The male patient had atrioventricular dissociation while the female patient 
died before ECG could be taken.  The case fatality rate was 1.88%. Bose TK et al (1999) 
observed a case fatality rate of 4.6% among 300 patients in eastern India7. In Srilankan 
studies,  Eddleston M et al  observed a case fatality rate of approximately 10%4.  The 
lower  case  fatality  rate  in  the  present  study  may be  due  to  les  severe  poisoning in 
Tamilnadu when compared to that in Srilanka and probably due to lesser number of 
patients  studied.   As  the  death  were  very  few,  there  was  no statistically  significant 
difference in outcome among no, some and severe cardiotoxicity groups and also there 
was no statistically significant difference in outcome among male and female patients. 
Areas of further work
1.   The  efficacy  of  anti  –  digoxin  Fab  fragments  in  treating  serious  cardiac 
arrhythmias induced by yellow oleander has been established by Eddleston M et 
al  (2000)  in  the  only  small  randomized  clinical  trial  involving  66  patients10. 
Further studies are required to confirm the efficacy of anti-digoxin Fab fragments 
in treating serious cardiac arrhythmias induced by yellow oleander. 
2.     Rapid detection of oleander poisoning with Digoxin III, a new   digoxin assay   as  
shown by Dasgupta A, Risin SA, Reyes M, Actor JK (2008)33.Further studies with 
regard to this is necessary to confirm its use in rapid detection of  yellow  oleander 
poisononing.
3.    Multiple doses of activated charcoal was found to be safe and more effective than 
single  does  activated  charcoal  in  reducing  death  and  life  threatening  cardiac 
arrhythmias after yellow oleander poisoning in the only single-blind, randomized 
placebo-controlled trial in Srilanka9,31,36. Further studies are required to confirm the 
superiority  of  multiple  doses  of  activated  charcoal  over  single  dose  activated 
charcoal in yellow oleander poisoning . Further studies are required to confirm the 
superiority  of  multiple  doses  of  activated  charcoal  over  single  dose  activated 
charcoal in yellow oleander poisoning. 
4.      Focal myocardial edema has been noted in cases of yellow oleander poisoning7. So 
studies  can  be  taken  up  to  assess  whether  glucocorticoids  have  any  role  in 
improving outcome in this poisoning. 
CONCLUSIONS
1. The  incidence  of  yellow  oleander  poisoning  in  general  medicine  wards  of 
Coimbatore Medical College Hospital ,Coimbatore during the study period was 
11.8 per 1000 admissions. 
2. Yellow oleander poisoning was most commonly observed among young adults 
and adolescents.
3. Although  there  was  a  slight  female  preponderance  the  difference  was  not 
statistically significant. 
4. Most of the patients were from rural areas belonging to upper lower and lower 
socio-economic class.
5. Most of the cases occurred during day time (6am – 6pm).
6. In majority of cases, the intention was suicidal secondary to interpersonal conflict, 
grief reaction, situational reaction, unemployment etc. 
7. The most common symptoms of yellow oleander poisoning in the present study 
were vomiting, giddiness and diarrhea.
8. Electrocardiographic  changes  noted  in  the  present  study  were  mainly  due  to 
depressed conduction. Most common abnormalities were sinus bradycardia, ST – 
T changes similar to digoxin effect / toxicity, first  – degree AV block, third – 
degree AV block and sino-atrial block.
9. Hyperkalemia as a manifestation of yellow oleander poisoning was uncommon in 
the present study compared to Srilankan studies.
10. There was a higher incidence of cardiotoxicity as the quantity of poison increased 
but even ingestion of one seed / fruit was found to cause severe cardiotoxicity. 
11. There was a higher incidence of cardiotoxicity in those who had taken the seeds / 
fruits crushed when compared to those who had chewed or swallowed the poison. 
12. Cardiotoxicity was found to be higher in patients who had consumed the poison in 
empty stomach than after food. 
13. Delay in inducing emesis or giving gastric lavage was associated with increased 
incidence of cardiotoxicity.
14. The  occurrence  of  cardiotoxicity  was  higher  in  patients  who  had  vomiting, 
diarrhea or altered mental status compared to patients who did not have any of 
these symptoms.
15. The mean serum potassium values at presentation were higher in patients who had 
cardiotoxicity when compared to patients who had no cardiotoxicity.
16. Case  fatality  rate  was  low  in  the  present  study  when  compared  to  previous 
Srilankan and Indian studies. 
SUMMARY
                  Yellow oleander poisoning is a common method of suicide in South India and 
Srilanka with thousands of cases occurring in Srilanka each year at present. This study 
was undertaken to find out the incidence of yellow oleander poisoning in our hospital, to 
study  the  clinical  aspects,  to  find  out  correlation  between  clinical  and  biochemical 
parameters with electrocardiographic changes and to find out possible risk factors for 
cardiotoxicity and outcome. 
After institutional ethical clearance, with an informed consent and with inclusion 
and exclusion criteria 106 cases of yellow oleander poisoning were included in the study 
and were evaluated on clinical, biochemical and electrocardiographic aspects.  The data 
were entered in Microsoft Excel spread sheet and analysed statistically in SPSS software 
The incidence of yellow oleander poisoning in general  medicine wards of our 
hospital was 11.8 per 1000 admissions. 53.8% of the cases were females.  The mean age 
of  poisoning was 27+ 10 years.   The  intention was suicidal  in  majority.   The most 
common symptoms were vomiting, numbness of tongue and lips, giddiness and diarrhea. 
The most  common abnormal ECG findings were sinus bradycardia,  ST – T changes 
similar to that described for digoxin effect / toxicity, sino-atrial block, first – degree AV 
block and third – degree AV block.   Depending on the ECG changes,  patients were 
decided into no, some and severe cardiotoxicity groups and relationship between various 
factors  and cardiotoxicity  analysed.   The mean number  of  seeds /  fruits  ingested  in 
patients who had cardiotoxicity was higher than in patients who had no cardiotoxicity. 
Majority had taken the poison crushed and in empty stomach which resulted in greater 
cardiotoxicity.  Delay in inducing emesis or giving gastric lavage was associated with 
greater cardiotoxicity.  The occurrence of cardiotoxicity was higher in patients who had 
vomiting,  diarrhea  or  altered  mental  status.   The  mean  serum  potassium  values  at 
presentation were higher in patients who had cardiotoxicity. Hyperkalemia was noted in 
only two cases.  The mean duration of hospital stay was 5 + 1.5 days and was higher in 
patients who had cardiotoxicity.  The case fatality rate was 1.88%.
Yellow oleander poisoning was found to be a common method of suicide among 
young adults and adolescents in this part of the country and was slightly more common 
in females.  It accounted for 13.1% of cases among the total number of poisoning cases 
during the study period.  Most of the patients were from rural areas belonging to upper 
lower and lower socio – economic class. The most common symptoms were vomiting, 
numbness  of  tongue  and  lips,  giddiness  sand  diarrhea.   The  most  common 
electrocardiographic abnormalities were sinus bradycardia, ST – T changes similar to 
digoxin effect ./ toxicity, first-degree AV block, third-degree AV block and sino-atrial 
block.  Hyperkalemia was found to be uncommon when compared to previous Srilankan 
studies.   The occurrence of cardiotoxicity was greater in patients who had taken the 
poison crushed and in empty stomach, who had taken more quantity of poison, in whom 
there  was  a  delay  in  inducing  emesis  or  giving  gastric  lavage,  who  had  vomiting, 
diarrhea  or  altered  mental  status  and  who  had  higher  serum  potassium  levels  at 
admission.  The more severe the cardiotoxicity more was the duration of hospital stay. 
The case fatality rate was low when compared to previous studies. 
Although this  study  could  identify  the  risk  factors  for  cardiotoxicity,  the  risk 
factors associated with poor outcome could not be well established as the deaths were 
very few.  Hence further studies are required to identify risk factors associated with poor 
outcome  in  this  poisoning.   Further  studies  are  also  required  to  assess  the  role  of 
glucocorticoids in  improving outcome.   The benefit  reported with multiple  doses  of 
activated charcoal and           anti-digoxin Fab fragments also need to be confirmed by 
further studies. 
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DEPARTMENT OF GENERAL MEDICINE , COIMBATORE MEDICAL COLLEGE 
HOSPITAL.
A  STUDY OF CLINICAL ,BIOCHEMICAL AND ELECTROCARDIOGRAPHIC ASPECTS OF 
YELLOW OLEANDER POISONING
Informed consent form for prospective participants
Principal Investigator: Dr Abhishek S, Junior Resident.
Research Guide:         Prof. Dr. Ramasamy.MD. Chief, Medical Unit – IV.
Organization: Department of Medicine, Coimbatore Medical College Hospital.
This informed consent form has two parts
PART – I  INFORMATION SHEET(to share the information about the research with you)
PART – II CERTIFICATE OF CONSENT (for signatures if you agree to take part)
(You will be given a copy of the full informed consent form.)
PART – I  INFORMATION SHEET
I , Dr Abhishek S, Junior resident in Dept of Medicine invites you to join as participant in my 
research on Yellow oleander poisoning, which is a  common poisoning in our state. I am going 
to give you information and invite you to be part of this research. You do not have to decide 
today whether or not you will participate in the research. Before you decide, you can talk to 
anyone you feel comfortable with about the research. 
There may be some words that you do not understand. Please ask me to stop as we go 
through the information and I will take time to explain.  If you have questions later, you can  
ask them to me, the study doctor or the staff.
                Yellow  oleander  poisoning results in a variety of manifestations and as it is a cardiac toxin 
,majority of it impacts are  on the cardiovascular system  in the form of conduction defects .It 
can also result in variations of ions like potassium and sodium which is normally present in 
the body. We are doing this research to learn the various aspects this poisoning in our 
population and to identify various risk factors so that we can have better understanding of this 
poisoning and to compare with other population type and finally  treatment efforts in a better 
way.
In this study you will have to answer questions regarding your illness, undergo a physical 
examination , give  blood for tests, undergo  an electrocardiogram.
You are being selected because we are inviting all adults with acute yellow oleander 
poisoning to enroll in the study.
Your participation in this research is entirely voluntary. It is your choice whether to participate  
or not. Whether you choose to participate or not, all the services you receive at this clinic will  
continue and nothing will  change. You may change your mind later and stop participating 
even if you agreed earlier.
You will have to give details regarding your age,sex,occupation,time/place/quantity of poison 
consumption,regarding  treatment  obtained  outside  if  so,  duration  of  disease,  family  ,past  
medical/ mental  illness  symptoms you are having at present, and current medications. A 
doctor will examine you to look for any problems. Your general condition will be recorded. All  
the data will  be recorded in a proforma. Ten ml of  blood will  be drawn for doing various 
laboratory  tests  to  know  about  the  status  of  your  disease.  Any  excess  sample  will  be 
destroyed immediately after the laboratory tests are completed. Taking the blood sample will  
produce some pain and there may be slight redness at the site of puncture for a day or two.  
You will be subjected to a  electrocardiogram(ECG) which will be recorded and it is a painless 
procedure.
On the first day you will be asked about your problems, a doctor will check you up and an 
ECG will be taken. You will also have to give the blood  sample for examination.
If you participate in this research you will be having a thorough check up, which may reveal 
some unidentified problems in you. We will  promptly start the treatment for them. Also by 
participating you are providing valuable data that will help doctors understand this disease 
better and ultimately serve the patients in a better way.
We will not be providing any money for participating in this research, you may incur more 
expense since you will have to visit the hospital more frequently.
It is possible that if others in the community are aware that you are participating in this 
research, they may ask you questions. We will not be sharing the identity of those 
participating in the research with anyone. The information that we collect from this research 
project will be kept confidential. Information about you that will be collected during the 
research will not be identified by your name but by a number. Only the researchers will know 
what your number is and they will lock that information up with a lock and key. It will not be 
shared with or given to anyone except my research guide.
The knowledge that we get from doing this research will be shared with you before it is made 
widely available to the public. Confidential information will not be shared. There will be small 
meetings in the community and these will be announced. After these meetings, we will publish 
the results in order that other interested people may learn from our research
You do not have to take part in this research if you do not wish to do so. You may also stop 
participating in the research at any time you choose. It is your choice and all of your rights will 
still be respected
If you have any questions you may ask them now or later, even after the study has started. If 
you wish to ask questions later, you may contact 
Dr  Abhishek S,               Prof .Dr. Ramasamy .MD
Junior Resident, Chief, Medical Unit – IV,
Dept Of Medicine, Dept Of Medicine,
Coimbatore Medical College Hospital Coimbatore Medical College Hospital,
Coimbatore – 18. Coimbatore- 18.
Phone – 9994610934. Phone – 9443366133.
This proposal has been reviewed and approved by the Ethics Committee of Coimbatore 
Medical College Hospital which is a committee whose task it is to make sure that research 
participants are protected from harm.
PART – II CERTIFICATE OF CONSENT
I have been invited to participate in research on diabetes. I understand that it will involve 
answering a detailed questionnaire, undergoing a thorough physical exam, giving blood and 
urine samples and two or three  follow-up visits. I have been informed that the risks are 
minimal and may include only slight pain and redness at sight of needle prick. I am aware that 
there may be no benefit to me personally and that I will not be compensated monetarily. I 
have been provided with the name of a researcher who can be easily contacted using the 
number and address I was given for that person.
I have read the foregoing information or it has been read to me. I have had the opportunity to 
ask questions about it and any questions I have asked have been answered to my 
satisfaction. I consent voluntarily to participate as a participant in this research and 
understand that I have the right to withdraw from the research at  anytime without in anyway 
affecting my medical care.
Name of the participant: ________________________________________________
Signature of the participant: ________________________________________________
Date: ________________________________________________
(Day/Month/Year)
If illiterate
A literate witness must sign (if possible , this person should be selected by the participant and 
must have no connection to the research team)
I have witnessed the accurate reading of the consent form to the potential participant , 
translated to his mother tongue,  and the individual has had opportunity to ask questions. I 
confirm that the individual has given consent freely.
Name of witness: _________________________ AND       Thumb print of 
participant
Signature of witness: _________________________
Date : _________________________
(Day/Month/Year)
I have accurately read or witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm that the 
individual has given consent freely.
Name of the researcher: ______________________________________
Signature of the researcher: ______________________________________
Date: ______________________________________
(Day/Month/Year)
                                                           PROFORMA
CLINICAL,BIOCHEMICAL AND ELECTROCARDIOGRAPHIC  ASPECTS OF 
YELLOW OLEANDER POISONING
Name                                                 Age               Sex               IP No
Occupation                                  Income
DOA                           DOD                            Duration of Hospital stay
Religion
Marital Status
Address
SOCIAL PROFILE
Place of ingestion    :
Part ingested            : leaves/flower/fruit/seeds/roots/others
Quantity of Poison  :
Method of ingestion:
Mixed with              :
Consumption           : Empty stomach/ After food(         )hrs
Intention                  :suicide/Accidental/Homicidal/others
Reason for  ingestion:
TIME  PROFILE
Time of ingestion:
Time after which family members came to know
First aid at home                                                             Time
Treatment by other doctors/hospital                               Time
                                                                                        Time of admission
Underlying Psychiatric  Disease     Y/N              if yes.
Other diseases:
Women – LMP                                            Pregnancy    Y/N
CLINICAL  PROFILE
GI  - Nausea/Vomiting/Abdominal pain/Diarrhoea/Anorexia
CNS- Giddiness/Headache/fatigue/weakness/numbness of tongue and lips/altered mental 
status/ seizures
Visual- Blurred vision / scotomas / flashes of light /Xanthopsia
Cardiac- Palpitations/shortness of birth/chest pain/chest discomfort
PHYSICAL EXAMINATION
Pulse rate                            Rhythm                                Volume
BP                        RR                febrile/ afebrile                                      Dehydration –
No/some/severe           
Pallor/icterus/cyanosis/clubbing/LNE/pedal oedema
CNS- level of consciousness
Tone                                DTR                       Plantar
INVESTIGATIONS                                                                                                
                                                                                                                                           E
CG         ALL LEADS
BLOOD UREA
RANDOM BLOOD SUGAR
 S CREATININE
 S SODIUM
S POTASSIUM
                                                                                                                           RHYTHM 
STRIP
TREATMENT GIVEN
Gastric  Lavage                        -Y/N
Activated Charcoal                  - Y/N
Inj Atropine                             - Y/N
T.Orceprenaline                      - Y/N
Steroids                                   -Y/N
Others                                      -Y/N                   Specify
OUTCOME  -- IMPROVED / EXPIRED  /Against Medical Advice / 
ABSCONDED/Discharge at request
                                    MASTER CHART KEY
YELLOW OLEANDER POISONING
1.Sex                                 Male-  1                 Female – 2
2. Marital status                Married- 1             Unmarried – 2
                                          Divorcee- 4           Widow – 5           Widower- 6
3. Part ingested                 Fruit- 1                  Seed/Kernel -2   Flower -3
                                         Leaves – 4              Root- 5         Other parts- 6
4. Method of ingestion    Crushed  - 1  Chewed – 2
                                         Swallowed – 3   Others – 4
5. Consumption in           Empty stomach – 1 After food – 2
6. Intention                      Suicidal -1   Accidental-2
                                        Homicidal – 3  Others -4
7. First Aid                      Given – 1    Not given -  2
8. Treatment by other Doctors  Yes – 1     No- 2 
9. Vomiting                            Yes – 1     No- 2
10. Abdominal pain             Yes – 1     No- 2
11. Diarrhoea                        Yes – 1     No- 2
12. Giddiness                        Yes – 1     No- 2
13.  Numbness of tongue and lips   Yes – 1     No- 2
14. Altered  Mental status             Yes – 1     No- 2
15. Blurred Vision                  Yes – 1     No- 2
16. Palpitations                       Yes – 1     No- 2
17. Shortness of  Breath        Yes – 1     No- 2
18. Pulse rhythm        Regular- 1      Irregular -  2
19. Sinus rhythm                    Yes – 1     No- 2
20. Sinus Bradycardia          Yes – 1     No- 2
21. Sinus Arrest or exit block    Yes – 1     No- 2
22. Atrial ectopics                  Yes – 1     No- 2
23.Junctional Rhythm          Yes – 1     No- 2
24.AV dissociation               Yes – 1     No- 2
25. I deg AV block                Yes – 1     No- 2
26. II deg AV block       Mobitz type I  -1  Mobitz type 2 - 3
27. III deg AV block            Yes – 1     No- 2
28.ST- T changes               Yes – 1     No- 2
29.Gastric Lavage              Yes – 1     No- 2
30. Inj Atropine               Yes – 1     No- 2
31. Tab Orciprenaline       Yes  – 1     No- 2
32. Steroids                           Yes – 1     No- 2
33. Outcome                 Improved – 1  Expired – 2 
                                     Against medical advice – 3    Absconded – 4
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1 rajesh          1 16 1 2 9 9 1 2 1 2 1 4 1 8 30 1 1 4 1 2 2 2 2 2 2 1
2 suja            1 14 2 2 9 9 6 2 1 1 2 1 2 20 . . 2 15 2 1 1 1 2 2 2 2
3 raghu           1 20 1 2 2 1800 7 1 5 2 2 4 2 21 360 3 1 61 1 2 1 1 2 2 2 2
4 rajila          1 18 2 1 9 9 7 1 3 1 1 1 1 10.3 30 1 1 3 1 2 1 1 2 2 1 1
5 sajila          1 17 2 2 9 9 6 1 5 1 2 1 1 11.3 60 1 1 3 1 2 1 1 2 2 2 2
6 ummathal        3 30 2 1 1 800 2 1 1 2 2 1 1 10 30 1 1 2 1 2 2 2 2 2 2 2
7 sangar          3 31 1 3 1 1000 6 2 3 2 2 1 1 17.3 . . 2 19 1 2 1 1 2 2 2 2
8 raju            2 25 1 2 3 2400 4 2 6 1 1 1 1 11 . . 2 12 1 2 2 2 2 2 2 2
9 suresh          2 28 1 1 4 3000 5 2 4 2 1 1 1 14 . . 1 1 1 2 1 1 2 2 2 2
10 chinnan         1 20 1 1 2 1125 4 2 4 2 1 1 1 8.3 . . 2 . 1 2 1 1 2 2 1 2
11 suresh          1 18 1 2 3 2000 5 1 25 1 1 4 1 10.3 . . 2 4 1 2 2 2 2 2 2 2
12 reema           2 27 2 1 9 9 6 2 3 1 1 4 1 11 60 1 1 3 1 2 1 1 2 2 2 2
13 sajeena         2 27 2 1 1 900 5 1 3 1 1 1 1 13 120 2 1 4 1 2 1 1 2 2 2 2
14 kumar           2 23 1 2 2 1800 3 2 2 3 2 1 1 11 . . 2 2 2 2 2 2 2 2 2 2
15 meena           2 24 2 5 1 500 4 2 4 2 1 1 1 7 30 1 1 5 1 2 1 1 2 2 2 2
16 princy          2 22 2 1 9 9 4 2 3 1 2 1 1 18 . . 2 4 1 2 2 2 2 2 2 2
17 saju            2 26 1 1 4 3000 6 2 5 2 2 1 1 12 15 1 1 2 2 2 1 1 2 2 1 2
18 nataraj         4 45 1 1 2 1500 5 1 6 9 1 1 1 13 10 1 1 3 1 2 1 1 2 2 2 2
19 mailal          2 21 2 1 1 300 4 1 1 1 1 4 1 8.15 . . 2 2 1 2 2 2 2 2 2 2
20 suresh          4 40 1 1 1 600 6 2 4 2 1 1 2 5.2 130 3 1 10 1 2 2 2 2 2 2 2
21 rajesh          1 16 1 2 9 9 4 1 2 3 2 4 1 17 60 1 1 6 1 2 2 2 2 2 2 2
22 siva            1 15 1 4 1 500 6 1 6 1 1 1 2 5 . . 2 16 1 2 1 1 2 2 2 2
23 agil            2 28 1 2 1 500 3 1 2 2 1 1 1 18 . . 2 4 1 1 1 1 2 2 1 2
24 geeta           2 25 2 3 9 9 5 1 4 1 1 1 1 12 360 3 1 7 1 2 1 1 2 2 2 2
25 veena           3 32 2 1 1 600 4 2 3 3 1 4 2 23 . . 2 11 1 2 1 1 2 2 1 2
26 rani            2 27 2 1 5 6000 5 2 5 2 1 1 1 15 . . 2 5 1 2 1 1 2 2 2 2
27 sheela          2 28 2 2 2 1500 3 2 2 2 2 1 2 21 15 1 1 . 2 2 2 2 2 2 2 2
28 nataraj         4 45 1 1 3 2500 6 1 3 1 2 4 1 14 . . 2 2 2 2 2 2 2 2 2 2
29 sivan           2 25 1 1 2 1800 2 1 1 1 1 1 1 8 . . 1 . 2 2 2 2 2 2 2 2
30 kamal           1 19 1 2 2 1800 2 2 3 3 2 4 2 20.3 10 1 2 . 2 2 2 2 2 2 2 2
31 seeta           2 25 2 1 9 9 3 1 1 1 2 1 1 11.3 . . 2 4 1 2 2 2 2 2 2 2
32 manju           2 28 2 1 1 600 4 1 1 2 1 1 1 11 . . 1 . 1 2 2 1 2 2 2 2
33 anuja           1 20 2 2 9 9 3 1 3 1 2 1 1 10.3 15 1 2 8 1 1 2 1 2 2 2 1
34 aarthi          3 32 2 1 9 9 6 1 3 2 1 1 1 16 . . 2 5 1 2 1 2 2 2 2 2
35 jancy           4 42 2 1 2 1800 1 1 1 2 2 4 1 14 . . 1 2 2 2 2 2 2 2 2 2
36 saju            3 39 1 1 3 2100 2 2 2 2 1 1 1 8.3 30 1 2 7 1 2 2 2 2 2 2 2
37 liju            1 19 1 2 2 1500 2 1 1 3 2 4 1 9 15 1 2 4 2 2 2 2 2 2 2 2
38 kritka          1 20 2 1 9 9 5 2 3 1 2 1 1 6 30 1 1 4 1 1 2 2 2 2 2 2
39 deepak          3 30 1 1 3 2000 5 2 5 1 1 1 1 17 . . 1 . 1 2 1 1 2 2 1 2
40 tamil           1 17 2 2 2 1650 6 1 3 1 1 1 1 17 60 1 1 5 1 2 1 1 2 2 2 1
41 sai             3 32 2 1 9 9 4 1 2 2 1 1 1 14 . . 2 1 1 1 2 1 2 2 1 2
42 thangam         2 26 1 2 2 1500 6 2 3 1 2 1 2 4 15 1 1 17 1 2 1 2 2 2 2 2
43 preena          2 21 2 3 9 9 4 1 3 1 1 1 1 10 420 3 2 14 1 2 2 1 2 2 2 2
44 manoj           2 25 1 2 3 2000 5 2 5 1 2 1 1 13.3 . . 1 23 1 2 2 2 2 2 2 2
45 malliga         2 25 2 1 1 200 4 1 2 2 1 1 1 17 . . 1 5 2 2 2 1 2 2 1 2
46 meena           1 19 2 1 2 1500 5 1 2 1 2 1 1 12.3 5 1 1 2 1 2 2 2 2 2 2 2
47 prem            1 18 1 2 5 8000 4 1 4 1 1 1 2 19 75 2 2 5 2 2 2 1 2 2 1 1
48 keran           4 54 1 1 1 900 5 1 2 2 1 1 2 2 180 3 2 5 1 2 1 1 2 2 1 1
49 kavya           4 55 2 5 9 9 6 1 2 1 1 1 1 17.3 . . 2 2 1 1 2 1 2 2 2 2
50 lakshmi         2 26 2 1 2 1200 9 2 10 1 1 1 1 10 . . 2 6 1 1 1 1 2 2 2 1
51 reeja           2 25 2 1 1 75 4 1 2 1 2 1 1 12 . . 2 12 1 1 2 1 2 2 2 2
52 sundarammal     4 50 2 1 1 600 4 1 1 1 1 1 2 19 . . 2 2 1 2 1 1 2 2 2 2
53 manju           1 18 2 2 1 25 5 2 3 2 2 1 1 14 . . 2 . 1 2 2 1 2 2 1 2
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1 2 88 1 100 60 1 2 2 2 2 2 2 2 2 2 2 1 92 24 0.8 139 4 1 2 2 2 4
2 2 84 2 120 70 2 2 2 1 2 2 2 2 2 2 2 3 89 17 0.8 155 4.9 1 1 1 2 1
3 2 60 1 120 80 2 1 2 2 2 2 2 1 2 2 1 2 102 46 1.2 136 4.6 2 1 1 2 1
4 2 66 2 120 86 2 1 2 2 2 1 2 2 2 2 1 3 155 32 1.1 135 3.8 1 1 1 2 1
5 2 62 1 110 70 2 1 2 2 2 2 2 2 2 2 2 2 60 18 0.7 138 4 1 1 1 2 1
6 2 84 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 81 20 0.8 138 3.9 1 2 1 2 4
7 2 60 2 120 60 2 2 2 2 2 2 2 2 2 2 2 1 123 40 1 140 4.2 1 1 1 2 1
8 2 48 1 120 80 2 1 2 2 2 2 2 2 2 2 2 2 190 50 1 137 4.5 1 1 1 2 1
9 2 68 1 120 90 1 1 2 2 2 2 2 2 2 2 2 2 69 21 0.9 148 4.8 1 1 1 2 1
10 2 76 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 105 58 1.6 134 4.1 2 1 1 2 1
11 2 80 1 110 80 1 1 2 2 2 2 2 2 2 2 1 2 62 15 1.2 130 3.5 1 1 1 2 1
12 2 46 1 110 70 1 2 2 2 2 2 2 2 2 1 1 3 89 38 1 138 4.2 1 1 1 2 1
13 2 110 1 110 70 1 1 1 2 2 2 2 2 2 2 1 2 77 18 0.7 139 3.8 1 1 1 2 1
14 2 84 1 120 70 1 2 2 2 2 2 2 2 2 2 2 1 185 19 0.9 132 3.6 1 1 1 2 1
15 2 110 1 100 60 1 2 1 2 2 2 2 2 2 2 1 2 82 43 0.8 136 3.8 1 1 1 2 1
16 2 120 1 110 80 2 2 1 2 2 2 2 2 2 2 2 1 68 26 0.9 132 3.1 1 1 1 2 1
17 2 58 1 100 70 2 1 2 2 2 2 2 2 2 2 2 2 67 20 0.7 146 3.8 1 1 1 2 1
18 2 100 1 100 80 2 2 1 2 2 2 2 1 2 2 1 2 88 48 0.9 132 3.8 1 1 1 2 1
19 2 62 1 110 60 1 2 2 2 2 2 2 2 2 2 2 1 60 18 0.6 139 3.7 1 1 1 2 1
20 2 48 2 120 80 2 2 2 2 2 2 2 2 2 1 1 3 64 43 0.6 136 3.5 1 1 1 2 1
21 2 72 1 100 70 1 2 2 1 2 2 2 2 2 2 1 3 82 20 0.9 . 4.2 1 2 1 2 1
22 2 72 1 110 80 2 1 2 2 2 2 2 2 2 2 1 2 107 32 1.2 . 4.2 1 1 1 2 1
23 2 70 1 130 80 1 2 2 2 2 2 2 2 2 2 2 1 172 24 0.8 . . 1 1 2 2 1
24 2 58 2 100 70 2 1 2 2 2 2 2 2 2 2 1 2 145 21 0.8 . . 1 1 1 2 1
25 2 104 1 110 70 1 2 2 2 2 2 2 2 2 2 1 2 137 21 0.8 . . 1 2 1 2 1
26 2 80 1 100 70 1 2 2 2 2 2 2 2 2 2 2 1 68 29 0.9 . . 1 1 1 2 4
27 2 78 1 130 80 1 2 2 2 2 2 2 2 2 2 2 1 105 28 0.8 . . 1 2 1 2 1
28 2 80 1 150 100 2 1 2 2 2 2 2 2 2 2 2 2 86 19 1 . . 1 1 1 2 1
29 2 96 1 120 70 1 2 2 2 2 1 2 2 2 2 2 3 108 31 0.9 . . 1 2 2 2 4
30 2 92 1 90 70 1 2 2 2 2 2 2 2 2 2 2 1 80 22 0.7 . . 1 2 1 2 1
31 2 94 1 100 70 1 2 2 2 2 2 2 2 2 2 1 2 96 32 0.9 . . 1 2 1 2 1
32 2 90 1 140 90 2 1 2 2 2 2 2 2 2 2 2 2 81 18 0.8 . 3.8 1 2 1 2 1
33 2 120 1 130 80 2 2 1 2 2 2 2 2 2 2 2 1 130 34 0.9 . 4.5 1 2 1 2 1
34 2 56 2 100 70 2 2 2 2 2 1 2 2 2 2 1 3 113 21 0.8 136 4.2 1 1 1 2 1
35 2 92 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 118 16 0.9 140 4.1 1 2 1 2 4
36 2 68 1 100 70 1 2 2 2 2 2 2 2 2 2 2 1 104 28 1 138 3.9 1 2 1 2 4
37 2 86 1 120 70 1 2 2 2 2 2 2 2 2 2 2 1 82 18 0.9 136 4 1 2 2 2 1
38 2 90 1 130 90 1 1 2 2 2 2 2 2 2 2 1 2 90 18 0.8 . 4.2 1 1 1 2 1
39 2 42 2 110 70 2 1 2 2 2 2 2 2 2 2 2 2 72 35 1 136 4.1 2 1 1 2 1
40 1 110 2 90 60 2 2 2 1 1 2 2 2 2 2 2 3 65 26 0.7 132 4.8 1 1 1 2 1
41 2 110 1 110 80 1 2 1 1 2 2 2 2 1 2 2 3 70 20 0.7 . . 1 2 1 2 1
42 2 40 2 70 40 2 1 2 2 2 2 2 2 1 2 1 3 60 28 0.9 . . 1 1 1 2 1
43 2 64 1 90 70 1 2 2 2 2 2 2 2 2 2 1 2 98 31 0.9 138 4.1 1 2 1 2 1
44 2 84 1 110 80 1 1 2 2 2 2 2 2 2 2 1 2 72 28 0.9 138 3.9 2 1 1 2 1
45 2 76 1 140 100 1 1 2 2 2 2 2 2 2 2 1 2 112 26 0.8 143 3.9 1 1 1 2 1
46 2 70 1 110 80 2 1 2 2 2 2 2 2 2 2 1 2 87 23 0.7 138 4.1 2 1 1 2 1
47 1 100 1 120 76 1 1 2 2 2 2 2 2 2 2 2 2 86 30 0.9 136 4 1 1 1 2 1
48 2 64 2 140 100 2 1 2 2 2 2 2 2 2 2 1 2 87 25 1 138 3.9 1 1 2 2 1
49 2 66 1 100 70 1 1 2 2 2 2 2 2 2 2 2 2 82 28 0.9 132 5.1 1 1 1 2 1
50 2 102 1 120 80 1 2 2 2 2 2 2 2 2 2 1 2 64 30 1.4 136 3.8 1 1 1 2 1
51 2 102 1 130 86 1 2 2 2 2 2 2 2 2 2 2 1 64 20 0.8 138 3.7 2 1 1 2 1
52 2 82 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 101 40 1.4 140 3.9 1 1 1 2 1
53 2 96 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 77 26 0.7 136 3.2 1 2 1 2 4
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54 arun            2 25 1 2 9 9 1 1 1 3 2 4 2 21 . . 2 1 2 2 2 2 2 2 2 2
55 sujina          1 19 2 1 9 9 5 2 2 2 2 4 1 18 . . 2 2 1 2 2 1 2 2 2 2
56 mariya          2 23 2 1 9 9 6 1 3 1 1 1 1 7 . . 1 8 1 2 1 1 2 2 1 1
57 suresh          3 32 1 1 3 2000 5 1 4 2 2 1 1 17.3 75 2 2 3 1 2 1 2 2 2 1 2
58 megala          3 30 2 1 1 600 5 1 3 1 1 1 2 18.5 . . 2 2 1 2 2 1 2 2 2 2
59 geeta           1 20 2 1 9 9 3 2 1 1 1 1 2 1.3 . . 1 3 1 2 2 2 2 2 2 2
60 arun            2 23 1 1 3 2000 6 1 5 1 1 1 1 10 . . 1 3 2 2 1 1 2 2 2 2
61 rani            2 28 2 2 1 800 4 2 1 1 1 1 1 10 . . 2 2 1 2 2 2 2 2 2 1
62 shamila         1 18 2 2 1 600 6 2 2 2 1 1 1 8 . . 2 2 1 2 1 2 2 2 1 1
63 ganeshan        3 36 1 1 5 30000 4 2 2 1 1 1 1 10.3 . . 1 28 1 2 2 1 2 2 2 2
64 malliga         2 25 2 1 9 9 4 1 2 2 2 1 1 17 . . 2 28 1 1 2 1 2 2 2 2
65 priya           4 40 2 1 1 500 5 2 3 1 1 1 1 14.5 . . 1 9 1 2 2 2 2 2 2 1
66 shajina         1 20 2 3 9 9 5 2 5 2 1 1 1 14.5 . . 2 28 1 2 1 2 2 2 1 2
67 reena           2 27 2 1 2 1500 6 2 6 1 1 1 1 8.3 . . 2 3 1 2 2 1 2 2 1 1
68 vadivel         1 17 1 2 9 9 4 2 1 3 1 1 1 6 . . 2 5 2 2 1 2 2 2 2 2
69 murugan         3 38 1 1 2 1500 4 2 3 2 1 1 1 15 . . 2 2 1 2 2 1 2 2 2 2
70 suresh          2 27 1 1 5 12500 6 2 4 2 1 1 1 13 . . 2 2 2 2 1 2 2 2 2 1
71 jose            2 25 1 2 5 4000 6 2 4 2 1 1 1 13 . . 2 2 2 2 2 1 2 2 1 2
72 saranya         2 28 2 1 5 5000 6 1 4 1 1 1 1 6 . . 2 3 1 2 1 2 2 2 2 2
73 anuj            1 15 1 2 9 9 5 2 5 2 2 2 1 13.3 . . 2 3 2 2 2 1 2 2 1 1
74 arun            2 28 1 1 9 9 5 2 2 1 1 1 2 20.3 . . 2 2 1 2 2 1 2 2 2 1
75 suresh          3 32 1 1 4 3000 5 2 2 1 1 1 1 17.3 . . 2 3 1 2 2 1 2 2 2 1
76 saju            2 21 1 2 2 1600 1 1 1 3 1 4 1 7 . . 1 2 2 2 2 2 2 2 2 2
77 nataraj         3 37 1 4 2 1500 5 2 2 2 1 1 1 16 . . 1 1 2 2 2 1 2 2 2 2
78 geeta           1 20 2 4 9 9 4 2 4 2 1 1 1 10 . . 1 5 1 2 1 1 2 2 2 2
79 saji            3 31 1 1 2 1800 1 2 5 1 2 1 1 14.3 . . 2 4 1 1 2 1 2 2 2 1
80 rija            2 22 2 2 5 5000 5 2 5 1 1 1 1 17 . . 1 . 1 1 1 1 2 2 2 2
81 rani            1 18 2 2 2 1500 5 2 3 2 1 4 1 17.3 . . 1 3 2 2 2 2 2 2 2 2
82 satheesh        2 23 1 2 2 1500 3 2 2 3 1 4 1 14.3 . . 2 15 2 2 2 2 2 2 2 2
83 chinnan         2 25 1 1 9 9 3 1 3 2 1 4 1 7.3 . . 2 2 2 2 2 2 2 2 2 2
84 murugan         2 23 1 2 3 2000 8 2 4 2 1 1 1 9 . . 2 62 1 2 2 1 2 2 2 1
85 karthik         1 18 1 2 1 300 4 1 3 1 1 1 1 18 . . 2 62 1 2 2 2 2 2 2 2
86 manju           1 16 2 2 2 1200 5 1 0 1 2 2 1 9.3 . . 2 3 1 2 2 2 2 2 2 2
87 seeja           1 16 2 2 2 1500 5 1 1 1 2 1 1 9 . . 2 7 1 1 2 1 2 2 2 2
88 nataraj         4 50 1 1 1 600 5 1 2 2 1 1 1 9 . . 2 4 2 2 2 1 2 2 1 2
89 muthammal       4 62 2 5 1 900 7 1 1 2 1 1 1 7 . . 2 4 1 2 2 1 2 2 2 1
90 reena           1 19 1 2 1 1000 4 1 2 2 2 1 1 9 . . 1 6 1 2 1 1 2 2 2 2
91 sajinaa         2 27 1 2 1 1000 5 1 1 2 2 1 1 12 . . 1 2 1 1 2 1 2 2 2 1
92 rani            2 25 2 2 5 4000 8 1 1 2 1 1 2 22 . . 1 2 1 2 2 2 2 2 2 1
93 satheesh        2 27 1 1 5 5000 6 1 2 1 1 1 1 17.3 . . 2 3 2 2 2 1 2 2 2 2
94 geeta           3 30 2 1 9 9 5 1 2 1 1 1 1 9 . . 2 8 1 2 2 1 2 2 2 1
95 saranya         3 36 2 1 9 9 4 1 1 2 1 1 1 12 . . 1 2 2 2 2 2 2 2 2 2
96 malliga         2 22 2 2 4 3000 4 1 2 2 2 1 1 13 . . 2 11 2 2 2 2 2 2 2 2
97 lakshmi         2 23 2 2 1 750 5 1 2 1 1 1 1 14 . . 2 5 1 1 2 1 2 2 2 1
98 rani            1 18 2 2 2 1800 4 1 1 1 1 1 1 14 . . 2 3 1 2 1 2 2 2 1 2
99 nataraj         3 35 1 3 9 9 6 2 1 1 2 1 1 15 . . 1 7 1 1 2 2 2 2 2 2
100 sumesh          2 21 1 2 4 3000 5 1 1 1 2 1 1 10 . . 1 4 1 2 2 1 2 2 2 2
101 ponnammal       4 50 2 2 1 600 5 2 6 1 1 1 1 14 . . 2 6 1 1 1 1 2 2 2 1
102 saji            3 35 1 1 3 2800 5 2 4 1 1 1 1 15 . . 2 2 1 2 1 2 2 2 2 2
103 reena           1 13 2 2 9 9 4 2 2 1 2 1 1 16 10 1 1 4 2 2 2 2 2 2 2 2
104 shajila         1 18 2 2 1 800 6 2 5 1 2 1 1 10 390 3 1 9 2 2 2 1 2 2 1 2
105 geeta           2 28 2 1 9 9 2 1 1 3 1 4 1 7.3 45 1 1 2 2 2 2 2 2 2 2 2
106 meena           2 27 2 1 1 900 1 2 18 2 2 1 1 17.3 . . 2 1 1 2 2 1 2 2 2 1
Sl
 n
o
br
ea
th
ls
pu
ls
er
at
e
pu
ls
er
hy
SB
P
D
BP
si
nu
sr
hy
si
nu
sb
ra
d
si
nu
st
ac
h
ex
it
bl
k
at
ri
al
ec
t
jn
rh
yt
hm
AV
 d
is
s
fi
rs
td
eg
se
cd
eg
th
rd
 d
eg
st
 c
ha
ng
e
ca
rd
io
to
x
bl
d 
su
g
bl
d 
ur
ea
s 
cr
ea
t
so
di
um
po
ta
ss
m
ga
st
r l
vg
in
j a
tr
p
or
ce
pr
nl
n
st
er
oi
ds
ou
tc
om
e
54 2 92 1 120 70 1 2 2 2 2 2 2 2 2 2 2 1 104 18 0.8 140 4.1 1 2 2 2 1
55 2 86 1 100 70 1 2 2 2 2 2 2 2 2 2 2 1 69 16 0.7 139 4.2 1 2 1 2 1
56 2 100 1 90 60 2 1 1 2 2 2 2 2 2 1 2 3 79 27 0.9 129 4.4 2 1 1 2 1
57 2 108 1 120 70 1 1 1 2 2 2 2 2 2 1 2 3 132 22 0.8 137 3.6 2 1 1 2 1
58 2 110 1 110 70 2 1 1 2 2 2 2 2 2 2 1 2 88 28 1 137 4.7 1 1 1 2 1
59 2 86 1 120 70 1 2 2 2 2 2 2 2 2 2 1 2 60 20 0.7 149 5.6 1 1 1 2 1
60 2 80 1 110 80 1 1 2 2 2 2 2 2 2 2 1 2 124 26 0.9 143 3.9 1 1 1 2 1
61 2 86 1 120 70 1 2 2 2 2 2 2 2 2 2 1 2 61 27 0.8 160 4.1 1 1 1 2 4
62 1 90 1 110 80 2 2 2 2 2 2 2 2 2 1 1 3 85 36 1 138 4.2 1 1 1 2 1
63 2 100 1 110 70 1 2 2 2 2 2 2 2 2 2 1 2 130 20 0.9 143 3.6 1 2 1 2 1
64 2 64 1 120 70 1 2 2 2 2 2 2 2 2 2 2 1 73 18 0.6 132 3 2 1 1 2 1
65 1 80 1 150 70 1 2 2 2 2 2 2 2 2 2 1 2 120 26 0.9 142 4 1 1 1 2 1
66 2 70 1 120 70 1 1 2 2 2 2 2 2 2 2 1 2 76 18 0.8 138 3.5 1 1 1 2 1
67 2 88 2 130 70 2 2 2 1 2 2 2 2 2 2 1 3 62 24 1 143 4 1 1 1 2 1
68 2 94 1 110 80 1 2 2 2 2 2 2 2 2 2 2 1 77 25 0.8 133 3.7 1 2 1 2 1
69 2 60 1 120 90 1 2 2 2 2 2 2 2 2 2 2 1 104 28 0.8 140 4 1 2 1 2 1
70 2 84 1 110 70 2 2 2 1 2 2 2 2 2 2 1 3 157 5 0.9 138 4.4 1 1 1 2 1
71 2 84 1 100 70 1 2 2 2 2 2 2 1 2 2 2 2 110 22 0.6 145 3.9 1 1 1 2 1
72 2 60 1 100 70 2 2 2 2 2 2 2 1 2 2 1 2 121 26 1.2 138 4 1 1 2 2 1
73 2 96 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 88 28 0.6 136 4.6 1 2 1 2 1
74 2 88 1 120 70 1 2 2 2 2 2 2 2 2 2 2 1 92 30 1 146 4 1 2 1 2 1
75 2 58 1 110 60 2 1 2 2 2 2 2 2 2 2 2 2 62 44 1 142 4.2 1 1 1 2 1
76 2 86 1 100 80 1 2 2 2 2 2 2 2 2 2 2 1 84 18 0.8 138 4.1 1 2 2 2 4
77 1 92 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 103 20 0.9 136 4 1 1 1 2 1
78 2 74 1 110 70 1 2 2 2 2 2 2 2 2 2 1 2 60 37 1 130 4.8 1 1 1 2 1
79 2 36 1 90 80 2 2 2 2 2 2 1 2 2 2 2 3 . . . . . 2 1 1 2 2
80 2 52 2 100 60 2 2 2 2 2 2 2 2 2 2 2 . 130 21 0.8 139 4 1 1 1 2 1
81 2 86 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 60 28 0.9 138 4 1 2 1 2 1
82 2 66 1 120 80 2 1 2 2 2 2 2 2 2 2 2 2 74 16 0.7 137 4 1 1 1 2 4
83 2 96 1 110 80 1 2 2 2 2 2 2 2 2 2 2 1 75 16 0.8 122 3.2 1 1 1 2 1
84 1 80 2 110 70 2 1 2 2 2 2 1 1 2 2 1 3 80 23 0.8 140 3.8 1 1 1 2 1
85 2 56 1 110 80 1 2 2 2 2 2 2 2 2 2 2 1 79 42 0.9 136 3.9 1 1 2 2 1
86 2 100 1 100 80 1 2 2 2 2 2 2 2 2 2 1 2 78 40 0.8 145 4 1 1 1 2 1
87 2 80 1 100 70 1 2 2 2 2 2 2 2 2 2 2 1 75 24 0.9 138 3.4 1 1 1 2 1
88 2 42 1 100 70 2 2 2 2 2 2 2 2 2 1 2 3 88 24 1 136 4 1 1 1 2 1
89 2 120 1 110 70 2 1 1 2 2 2 2 2 2 2 1 2 77 18 0.8 142 4.1 1 1 1 2 1
90 2 68 1 110 60 1 2 2 2 2 2 2 2 2 2 2 1 88 34 0.9 140 3.6 1 2 1 2 4
91 2 60 1 110 70 2 1 2 2 2 2 2 2 2 2 2 2 67 37 1 138 3.6 1 1 1 2 1
92 2 60 2 110 90 2 2 2 1 2 2 2 2 2 2 1 3 58 16 0.7 136 3.5 1 1 1 2 1
93 1 68 1 130 70 1 1 2 2 2 2 2 2 2 2 2 2 82 34 0.9 139 4 1 1 1 2 1
94 1 80 1 110 90 1 1 2 2 2 2 2 2 2 2 1 2 62 33 0.7 142 4 1 1 2 2 1
95 2 96 1 120 60 1 2 2 2 2 2 2 2 2 2 2 1 72 30 0.9 144 3.5 1 1 1 2 1
96 2 80 1 130 80 1 2 2 2 2 2 2 2 2 2 2 1 110 49 0.8 138 3.4 1 2 2 2 1
97 2 50 1 90 80 2 1 2 2 2 2 2 2 2 1 2 3 120 31 1 148 4.5 1 1 1 2 1
98 2 60 2 100 70 2 2 2 2 2 2 2 1 2 2 1 2 86 55 1.3 140 4.5 1 1 1 2 1
99 2 98 1 110 70 1 2 2 2 2 2 2 2 2 2 2 1 126 25 0.8 144 4.5 1 2 1 2 1
100 2 92 1 120 70 1 2 2 2 2 2 2 2 2 2 2 1 67 21 0.8 130 4.3 1 2 1 2 1
101 2 88 1 150 90 1 2 2 2 2 2 2 2 2 2 1 2 235 34 1 137 4.3 1 1 1 2 1
102 2 54 1 140 80 2 1 2 2 2 2 2 1 2 2 1 2 62 16 0.9 138 3.6 1 1 1 2 1
103 2 140 1 100 70 2 2 1 2 2 2 2 2 2 2 2 1 80 25 0.6 132 4.2 1 1 1 2 1
104 2 120 1 110 70 2 1 1 2 2 2 2 2 2 2 1 2 128 72 1.8 140 3.4 1 1 1 2 1
105 2 92 1 110 80 1 2 2 2 2 2 2 2 2 2 2 1 88 28 0.8 141 4.1 1 2 2 2 4
106 2 48 2 70 40 2 2 2 2 2 2 2 2 2 2 2 2 . . . . . 2 1 2 2 2
